Luteinizing hormone and its dilemma in ovulation induction

Journal of Human Reproductive Sciences

Volumn 4, Issue 1, 2011, Pages 2-7

  Kumar, Pratap ^a   Sait, Sameer ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Effects on ovulation; LH ceiling; ovulation induction

Indexed keywords

AROMATASE; CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; GOSERELIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; SOMATOMEDIN C; STEROID HORMONE;

CELL PROLIFERATION; CORPUS LUTEUM; DOWN REGULATION; DRUG EFFECT; EMBRYO DEVELOPMENT; ESTRADIOL BLOOD LEVEL; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GRANULOSA CELL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; OOCYTE; OUTCOME ASSESSMENT; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; OVULATION; OVULATION INDUCTION; PROTEIN EXPRESSION; REVIEW; STEROIDOGENESIS;

EID: 79960217506     PISSN: 09741208     EISSN: 19984766     Source Type: Journal    
DOI: 10.4103/0974-1208.82351     Document Type: Review

References (21)

1. Zeleznik AL, Hillier SG. The role of gonadotropins in the selection of the preovulatory follicle. Clin Obstet Gynecol 1984;27:927-40. (Pubitemid 15224078)
2. Hillier SG, Whitelaw PF, Smyth CD. Follicular oestrogen synthesis: the two-cell, two-gonadotropin model revisited. Mole Cell Endocrinol 1994;100:51-4. (Pubitemid 24109526)
3. Balasch J, Creus M, Fabregues F, Civico S, Carmona F, Puerto B, et al. The effect of exogenous luteinizing hormone (LH) on oocyte viability: evidence from a comparative study using recombinant follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction. J Assist Reprod Genet 2001;18:250-6. (Pubitemid 32613766)
4. Tarlatzis B, Tavmergen E, Szamatowicz M, Barash A, Amit A, Levitas E, et al. The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: A double-blind, randomized, prospective study. Hum Reprod 2006;21:90-4. (Pubitemid 41794295)
5. Westergaard LG, Erb K, Laursen SB, Rex S, Rasmussen PE. Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: A prospective randomized study. Fertil Steril 2001;76:543-9.
6. Ferrari B, Barusi L, Coppola F. Clinical and endocrine effects of ovulation induction with FSH and hCG supplementation in low responders in the midfollicular phase: A pilot study. Reprod Med 2002;47:137-43. (Pubitemid 34204031)
7. Filicori M, Cognigni GE, Samara A, Melappioni S, Perri T, Cantelli B, et al. The use of LH activity to drive folliculogenesis: Exploring uncharted territories in ovulation induction. Hum Reprod Update 2002;8:543-57. (Pubitemid 35452780)
8. Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, Tabarelli De Fatis C, et al. Luteinzing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation. J Clin Endocr Metab 2001;86:337-43. (Pubitemid 32109815)
9. Howles CM. Role of LH and FSH in ovarian function. Mol Cell Endocrinol 2000;161:25-30. (Pubitemid 30201646)
10. Balasch J, Vidal E, Penarrubia J, Casamitjana R, Carmona F, Creus M, et al. Suppression of LH during ovarian stimulation: Analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in the down-regulated women stimulated with recombinant FSH. Hum Reprod 2001;16:1636-43. (Pubitemid 32761742)
11. Humaidan P, Bungum L, Bungum M, Andersen CY. Ovarian response and pregnancy outcome related to mid-follicular LH concentrations in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Hum Reprod 2002;17:2016-21.
12. Stanger JD, Yovich JL. Reduced in vitro fertilization of human oocytes from patients with raised luteinizing hormone concentrations during the follicular phase. Br J Obstet Gynaecol 1985;92:385-93. (Pubitemid 15114221)
13. Howles CM, Macnamee MC, Edwards RG,Goswamy R, Steptoe PC. Effect of high tonic concentrations of luteinising hormone on outcome on in-vitro fertilisation. Lancet 1986;30:521-2. (Pubitemid 16049547)
14. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 1988;22:1024-6.
15. Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 1990;336:1141-4. (Pubitemid 20362903)
16. Pagn YL, Srouji SS, Jimenez Y, Emerson A, Gill S, Hall JE. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: Investigation of hypothalamic and pituitary contributions. J Clin Endocrinol Metab 2006;91:1309-16.
17. McCartney CR, Eagleson CA, Marshall JC. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome. Semin Reprod Med 2002;20:317-26.
18. Chappel SC, Howles C. Re-evaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum Reprod 1991;6:1206-12.
19. Yoshimura Y, Wallach EE. Studies of mechanism(s) of mammalian ovulation. Fertil Steril 1987;47:22-34.
20. Shoham Z, Jacobs HS, Insler V. Luteinizing hormone: its role, mechanism of action, and detrimental effects when hyper secreted during the follicular phase. Fertil Steril 1993;59:1153-6.
21. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:524-9. (Pubitemid 34158214)